Journal article
Physicians' Perceptions of Factors Influencing the Treatment Decision-making Process for Men With Low-risk Prostate Cancer
Urology (Ridgewood, N.J.), Vol.107, pp.86-95
09/2017
DOI: 10.1016/j.urology.2017.02.056
PMCID: PMC5880528
PMID: 28454988
Abstract
To assess physicians' attitudes regarding multiple factors that may influence recommendations for active surveillance (AS) vs active treatment (AT) given the central role physicians play in the treatment decision-making process.
We conducted semistructured interviews to assess factors that physicians consider important when recommending AS vs AT, as well as physicians' perceptions of what their patients consider important in the decision. Participants included urologists (N = 11), radiation oncologists (N = 12), and primary care physicians (N = 10) from both integrated and fee-for-service healthcare settings.
Across the specialties, quantitative data indicated that most physicians reported that their recommendations for AS were influenced by patients' older age, willingness and ability to follow a surveillance protocol, anxiety, comorbidities, life expectancy, and treatment preferences. Qualitative findings highlighted physicians' concerns about malpractice lawsuits, given the possibility of disease progression. Additionally, most physicians noted the role of the healthcare setting, suggesting that financial incentives may be associated with AT recommendations in fee-for-service settings. Finally, most physicians reported spouse or family opposition to AS due to their own anxiety or lack of understanding of AS.
We found that patient and physician preferences, healthcare setting, and family or spouse factors influence physicians' treatment recommendations for men with low-risk PCa. These were consistent themes across physician subspecialties in both an Health Maintenance Organization and in fee-for-service settings.
Details
- Title: Subtitle
- Physicians' Perceptions of Factors Influencing the Treatment Decision-making Process for Men With Low-risk Prostate Cancer
- Creators
- Kimberly Davis - Department of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DC. Electronic address: kmd54@georgetown.eduPaula Bellini - Department of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DCCharlotte Hagerman - Department of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DCRiley Zinar - Department of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DCDaniel Leigh - Department of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DCRichard Hoffman - Division of General Internal Medicine, University of Iowa Carver College of Medicine/Iowa City VA Medical Center, Iowa City, IADavid Aaronson - Department of Urology, Kaiser Permanente, East Bay, Oakland, CAStephen Van Den Eeden - Division of Research, Kaiser Permanente Northern California, Oakland, CAGeorge Philips - Department of Medicine, MedStar Georgetown University Hospital Center, Washington, DCKathryn Taylor - Department of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DC
- Resource Type
- Journal article
- Publication Details
- Urology (Ridgewood, N.J.), Vol.107, pp.86-95
- DOI
- 10.1016/j.urology.2017.02.056
- PMID
- 28454988
- PMCID
- PMC5880528
- NLM abbreviation
- Urology
- ISSN
- 0090-4295
- eISSN
- 1527-9995
- Grant note
- P30 CA086862 / NCI NIH HHS R01 CA155578 / NCI NIH HHS
- Language
- English
- Date published
- 09/2017
- Academic Unit
- Epidemiology; General Internal Medicine; Internal Medicine
- Record Identifier
- 9984094361402771
Metrics
29 Record Views